Earnings Labs
Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc. (RCKT)

NASDAQ·Healthcare·Biotechnology

$3.44

-1.43%

Mkt Cap $384.11M

Analyst Ratings

Buy

4

Hold

0

Sell

2

Price Target (12 analysts)

$6.00

Range $5.00$7.00

Implied Upside

+74.4%

Consensus $6.00 vs current $3.44